Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/37536
Title: COMPLETE BLOOD COUNTS ARE FREQUENTLY ABNORMAL 1 YEAR AFTER DOSIMETRY-GUIDED RADIOACTIVE IODINE THERAPY for METASTATIC THYROID CANCER
Authors: Padovani, Rosalia P. [UNIFESP]
Tuttle, R. Michael
Grewal, Ravinder
Larson, Steve M.
Boucai, Laura
Universidade Federal de São Paulo (UNIFESP)
Mem Sloan Kettering Canc Ctr
Issue Date: 1-Mar-2014
Publisher: Amer Assoc Clinical Endocrinologists
Citation: Endocrine Practice. Jacksonville: Amer Assoc Clinical Endocrinologists, v. 20, n. 3, p. 213-220, 2014.
Abstract: Objective: Radioactive iodine (RAI) has been associated with hematologic abnormalities. Previous research has shown that even a single dose of RAI can cause changes in the peripheral complete blood count (CBC). It is unclear if the use of dosimetry guidance would prevent the effects of high doses of RAI on bone marrow suppression.Methods: CBC at baseline was compared to a CBC obtained 1 year after the last RAI treatment in 50 thyroid cancer patients that received >= 250 mCi RAI during the course of their disease. Cumulative dose, number of treatments, patients' age, and the use of external beam radiation therapy (EBRT) were considered in the analysis.Results: We observed a small but statistically significant decrease in hemoglobin (Hb), hematocrit (Hct), and platelet (Plt) counts at 1 year in 50 patients who had received >= 250 mCi RAI. We did not find a significant change in white blood cell count (WBC). Approximately 60% of patients who developed anemia had concomitant WBC and Plt abnormalities. RAI dose, number of treatments, and age at diagnosis did not confer a higher risk of bone marrow suppression.Conclusion: High cumulative activities of RAI administered under dosimetric guidance are associated with a small but statistically significant decreases in Hb, Hct, and Plt counts. the clinical implications of these changes, if any, are unclear. the benefits obtained with high doses of RAI, when indicated, are likely to outweigh the minimal hematologic risks observed in the present study.
URI: http://repositorio.unifesp.br/handle/11600/37536
ISSN: 1530-891X
Other Identifiers: http://dx.doi.org/10.4158/EP13172.OR
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.